Concepedia

Alain C. Mita

AC

Statistics

Publications

112

Citations

9.2K

H-Index

48

Active since

2003

Affiliations

Cedars-Sinai Medical Center(Current)

The University of Texas Health Science Center at San Antonio

Memorial Sloan Kettering Cancer Center

Sarah Cannon

The University of Texas MD Anderson Cancer Center

Alain C. Mita is an author at Cedars-Sinai Medical Center specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2003–2024

112

Publications

112

Avelumab, an Anti–Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study

Andrea B. Apolo, Jeffrey R. Infante, Ani Sarkis Balmanoukian et al. · Journal of Clinical Oncology · 2017 · 580 citations

LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer

Masoud Tavazoie, Ilana Pollack, Raissa Tanqueco et al. · Cell · 2018 · 472 citations · Full text

, , +5

Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer

Mary L. Disis, Matthew H. Taylor, Karen Kelly et al. · JAMA Oncology · 2019 · 417 citations · Full text

Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan–Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors

Josep Tabernero, Rastislav Bahleda, Rodrigo Dienstmann et al. · Journal of Clinical Oncology · 2015 · 371 citations

Phase I and Pharmacokinetic Study of XRP6258 (RPR 116258A), a Novel Taxane, Administered as a 1-Hour Infusion Every 3 Weeks in Patients with Advanced Solid Tumors

Alain C. Mita, Louis Denis, Eric K. Rowinsky et al. · Clinical Cancer Research · 2009 · 328 citations

1–5 of 112